Here we present two protocols, one for measuring the specific growth rate and the other for the cell-binding ability of rotavirus using the plaque assay and RT-qPCR. These protocols are available for confirming the differences in phenotypes between rotavirus strains.
Rotavirus is the main etiological factor for infantile diarrhea. It is a double-stranded (ds) RNA virus and forms a genetically diverse population, known as quasispecies, owing to their high mutation rate. Here, we describe how to measure the specific growth rate and the cell-binding ability of rotavirus as its phenotypes. Rotavirus is treated with trypsin to recognize the cell receptor and then inoculated into MA104 cell culture. The supernatant, including viral progenies, is collected intermittently. The plaque assay is used to confirm the virus titer (plaque-forming unit: pfu) of each collected supernatant. The specific growth rate is estimated by fitting time-course data of pfu/mL to the modified Gompertz model. In the assay of cell-binding, MA104 cells in a 24-well plate are infected with rotavirus and incubated for 90 min at 4 °C for rotavirus adsorption to cell receptors. A low temperature restrains rotavirus from invading the host cell. After washing to remove unbound virions, RNA is extracted from virions attached to cell receptors followed by cDNA synthesis and reverse-transcription quantitative PCR (RT-qPCR). These protocols can be applied for investigating the phenotypic differences among viral strains.
RNA viruses form a genetically diverse population, known as quasispecies1, because of their mutation rate,2 which is higher than that of DNA-based organisms. Population structure in quasispecies is affected by the population genetic factors, including mutation, selection pressure, and genetic drift. Strains within a single genetic lineage may show different phenotypes because of the genetic diversity. For example, Rachmadi et al. showed that free chlorine sensitivity was different among murine norovirus strains that originated from a plaque-purified strain S7-PP33.
Rotaviruses (genus rotavirus in reoviridae family) are non-enveloped ds RNA viruses forming quasispecies2. In addition to the population genetic factors described above, genome reassortment affects the genetic diversity of rotavirus because this virus has 11 segmented genomes4. Rotaviruses cause diarrhea mainly among infants, and infant deaths in 2013 were estimated about 250,0005. Two vaccines are in use in several countries and have been effective in reducing the burden of rotavirus infection, but some researchers are now discussing the presence of vaccine-escape mutants6,7,8,9. The characterization of these mutants is important to understand the vaccine-escape mechanisms.
Here, we present protocols for two assays for evaluating the specific growth rate and cell-binding ability of rotavirus in order to understand the phenotypic differences among strains/mutants. The growth curve of rotaviruses has been presented in previous reports10, but growth parameters such as specific growth rate are not usually measured. A cell-binding assay conducted previously involves the immunofluorescent staining technique11. We show here easier methods of using the plaque assay and RT-qPCR, which allow us to quantitatively discuss the difference in viral phenotypes. These methods are appropriate for the characterization of rotavirus phenotypes and may finally contribute to the construction of new vaccines effective for multiple genotypes.
1. Medium Preparation
2. Cell Culture
3. Specific Growth Rate of Rotavirus
NOTE: Rhesus rotavirus (RRV, genotype: G3P[3]) is utilized in this protocol because RRV can rapidly and easily form plaques with MA104 cells.
4. Cell-binding Assay
NOTE: This protocol is based on Gilling’s report13.
An overview of two protocols for the specific growth rate and cell-binding assay of plaque- purified RRV strains is shown in Figure 1A and 2A, respectively.
In the assay for the specific growth rate, the final virus titer reaches more than 107 pfu/mL when propagating on the T75 flask. If the maximum concentration is lower than 107 pfu/mL, the MA104 cell may not have become confluent or RRV was not activated well by trypsin. Some growth models are available for estimating the specific growth rate using the infectious unit data. In this protocol, the modified Gompertz model12 is employed as an example;
where N0 (104 pfu/mL in this study) and Nt (104 to 108 pfu/mL) are the virus infectious titer (pfu/mL) at 0 and t (example: 0, 6, 12, 18, 24, 36) hpi, respectively, A is the asymptotic value [log(N∞/N0)] (example: 3 to 4), µ is the specific growth rate [1/h], e is the Napier's constant and λ is the lag period [h]. Model parameters are obtained by the solver function of the analysis software, which minimizes the sum of squares of the difference between the observed and modeled values. In the example in Figure 1B, the specific growth rate (µ) is estimated to be 0.197 [1/h] and the lag period (λ) is 6.61 [h] by applying the least square method to a modified Gompertz model, and the relative virus titer at the stationary phase to the initial titer (log scale) (A) is 3.15 [log (N∞/N0)]. We have tested 6 rotavirus clones in total, and the estimated values of the specific growth rate ranged from 0.19 to 0.27 [1/h]. These estimated values are reliable because the coefficient of determination values in the model fitting is more than 0.98.
RRV virions binding to cell surfaces were about 103 copies/mL (binding efficiency was around 1%) when using a 24-well plate for the cell-binding assay (Figure 2B). The assay is usually conducted three times for every sample, and if a large variance in the copy number is observed in a sample, some problems such as over-washing and insufficient activation of RRV by trypsin may occur. The Ct value of qPCR exceeding about 36.0 is not preferable and is regarded to be below a detection limit in our qPCR condition.
Volume/ 1 reaction | |
5 x PrimeScript Buffer | 4.0 µL |
PrimeScript RT Enzyme Mix I | 1.0 µL |
Oligo dT Primer | 1.0 µL |
Random 6 mers | 4.0 µL |
Deionized distilled water | 6.0 µL |
ssRNA sample | 4.0 µL |
Total | 20.0 µL |
Table 1: Master mix composition for cDNA synthesis of rotavirus genome.
Temperature [°C] | Time |
37 | 15 min |
42 | 15 min |
85 | 5 s |
4 | ∞ |
Table 2: Reaction condition for cDNA synthesis of rotavirus genome.
Volume/1 reaction | |
Premix Taq | 12.5 µL |
Forward primer (10 µM) | 0.5 µL |
Reverse primer (10 µM) | 0.5 µL |
Probe (10 µM) | 0.5 µL |
Reference Dye II | 0.5 µL |
Deionized distilled water | 5.5 µL |
cDNA sample | 5.0 µL |
Total | 25 µL |
Table 3: Master mix composition for quantitative PCR of rotavirus A genome.
Temperature [°C] | Time | |
95 | 5 min | |
94 | 20 s | 45 cycle |
60 | 1 min | |
72 | 5 min |
Table 4: Reaction condition for quantitative PCR of rotavirus A genome.
Figure 1: Schematic overview of the estimation of rotavirus growth and the growth curve of rotavirus. (A) The infectious unit of rotavirus is measured with the plaque assay. (B) The curve (blue line) was approximated by the modified Gompertz model based on observed data in our laboratory (white circle). The specific growth rate [µ]; 0.197 [h-1], lag period (λ); 6.61 [h], the relative virus titer at the stationary phase to the initial titer (log scale) (A); 3.15 [log (N∞/N0)]. Please click here to view a larger version of this figure.
Figure 2: Schematic overview and representative result of the cell-binding assay of five RRV strains purified from plaques in our laboratory. (A) A cell culture plate inoculated with rotavirus is incubated at 4 °C for inhibiting the virus invasion into cells. After incubation and removing the unbound viral particles to cells, quantify the number of genomes originating from bound viral particles to the cell surface with RT-qPCR. (B) The result of the cell-binding assay was displayed as binding efficiency (%), which was the ratio of bound viral particles to those present in the inoculum. Bold bar: median, end of boxes: quartile deviation, end of line: maximum and minimum. Please click here to view a larger version of this figure.
Our protocol for measuring the specific growth rate is easier than previous ones and can be adapted for other viruses unless their cell culture system has not yet been established. In this study, we used RRV (G3P[3]) because this strain can form plaques easier than human rotaviruses when using MA104 cell lines. Some human rotavirus strains cannot form plaque in this cell line. Therefore, instead of the plaque assay, the focus forming unit (FFU) assay15 or median tissue culture infectious dose (TCID50) assay can be applied for many rotavirus strains16. The presented protocol for determining the specific growth rate can be used for other virus types but is not suitable for viruses for which no established cell culture system is established. Before starting the experiment for the specific growth rate, it is better to know in advance when the virus infectious titer starts to increase and reaches the stationary phase in a preliminary test. If too many plaques are present, the plaque assay should be conducted again after changing the dilution rate of the virus samples. The hours post-infection (hpi) to collect samples are also important because the slope of the exponential growth phase may be underestimated if the proper time point to reach the stationary phase is missed. In the approximation by the modified Gompertz model, a coefficient of determination should always be calculated and checked. If the fitness to the modified Gompertz model is low, other growth models such as the modified logistic model12 may be preferable.
In handling cells, when removing the medium or virus inoculum, the PBS for washing or agarose gel for plaque assay must be promptly added to each well of a cell culture plate to prevent the cells from dryness. At the same time, you must gently pour PBS or agarose to cells not to detach from wells. This step is the most important in both assays (step 3.9 and 3.11). If the plaque assay has too many samples, we recommend subdividing the agarose gel (100 mL each maximum is recommended) into several medium bottles and keeping the bottles warm until just before use since agarose gel is solidified within about 10 min at room temperature. Since trypsin is vulnerable to high temperatures17, a trypsin solution should be added to a medium and agarose for the plaque assay after adequately cooling down.
In the cell-binding assay, the incubation for virus binding to cells must be done at 4 °C to prevent invasion of the cells. According to Gilling's method13, cells are prone to drying at low temperatures, so gentle shaking is necessary every 15 min during incubation. The RNA extraction kit utilized here can be substituted for other kits. The slope of the standard curve in RT-qPCR should be approximately 3.3, and the coefficient of determination should be more than 0.98. Compared to the fluorescence microscope to visualize the localization of viruses in cells, the assay is more rapid and easier to use because binding of fluorescent substances to viruses is not necessary.
Recently, human intestinal enteroid (HIE), exhibiting a similar cellular composition and function as human gastrointestinal epithelium, has become available for rotavirus propagation18. The use of HIE may enable us to evaluate the specific growth rate and cell-binding ability of non-culturable strains of rotavirus. Also, both experiments described here may be applied to the evaluation of drug effects on both phenotypes19. The protocols presented here make it possible to quantitatively discuss the changes in phenotype parameter values of rotavirus strains under varied conditions.
The authors have nothing to disclose.
This work was supported by "The Sanitation Value Chain: Designing Sanitation Systems as Eco-Community Value System" Project, ResearchInstitute for Humanity and Nature (RIHN, Project No.14200107).
7500 Real Time PCR System | Applied Biosystems | qPCR | |
Agar-EPI | Nakalai Tesque, Inc | 01101-34 | Plaque assay |
Disodium Hydrogenphosphate | Wako Pure Chemical Corporation | 194-02875 | Cell binding assay |
Eagle's MEM "Nissui" | Nissui Pharmaceutical Co., Ltd | _05900 | Cell culture |
Eagle's MEM "Nissui" | Nissui Pharmaceutical Co., Ltd | _05901 | Plaque assay |
EasYFlask 75 cm2 | Thermo Scientific | 156499 | Cell culture |
Fetal bovine Serim, qualified, USDA-approved regions | Gibco | 10437028 | Cell culture and Plaque assay |
Forward / Reverse primers | Eurofins Genomics | qPCR | |
L-Glutamine, 200 mM Solution | Gibco | 2530081 | Cell culture and Plaque assay |
Neutral Red | Wako Pure Chemical Corporation | 140-00932 | Plaque assay |
PBS (-) "Nissui" | Nissui Pharmaceutical Co., Ltd | _05913 | Cell culture and Plaque assay |
Penicillin-Streptomycin, Liguid | Gibco | 15140122 | Cell culture and Plaque assay |
Potassium Chloride | Wako Pure Chemical Corporation | 163-03545 | Cell binding assay |
Premix ExTaq (Perfect Real Time) | TAKARA Bio Inc. | RR039A | qPCR |
PrimeScriptTN RT reagent Kit (Perfect Real Time) | TAKARA Bio Inc. | RR037A | cDNA synthesis |
PrimeTime qPCR Probes | Medical and Biological Laboratories Co., Ltd. | qPCR | |
QIAamp Viral RNA Mini Kit | QIAGEN | 52904 | RNA extraction |
Sodium Bicarbonate | Wako Pure Chemical Corporation | 199-05985 | Cell culture and Plaque assay |
Sodium Chloride | Wako Pure Chemical Corporation | 198-01675 | Cell binding assay |
Tissue culture plates 24-well plate | TPP | 92024 | Cell binding assay |
Tissue culture plates 6-well plate | TPP | 92006 | Plaque assay |
Trizma base | SIGMA-ALDRICH | T1503 | Cell binding assay |
Trypsin from porcine pancrease | SIGMA-ALDRICH | T0303-1G | Activate for rotavirus |
Trypsin-EDTA (0.05 %), phenol red | Gibco | 25300054 | Cell culture |
Vertical 96-Well Thermal Cycler | Applied Biosystems | cDNA synthesis |